A case of pyoderma gangrenosum possibly associated with sunitinib treatment

International Journal of Dermatology

Volumn 52, Issue 5, 2013, Pages 634-636

  Ueharaguchi, Yuri ^a   Kabashima, Kenji ^b   Sasahashi, Makiko ^a   Matsuda, Ayumu ^a   Matubara, Kunihiko ^c   Matsui, Miho ^a  

^a Ijinkai Takeda General Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Otowa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SUNITINIB;

ADULT; BACTERIUM CULTURE; CASE REPORT; ERYTHEMA; HUMAN; KIDNEY CARCINOMA; LEG ULCER; LETTER; MALE; MEDICAL HISTORY; METASTASIS; NEUTROPHIL CHEMOTAXIS; PSORIASIS VULGARIS; PYODERMA GANGRENOSUM; SKIN BIOPSY; TREATMENT DURATION;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; DRUG ERUPTIONS; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PREDNISONE; PYODERMA GANGRENOSUM; PYRROLES;

EID: 84876427608     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.04952.x     Document Type: Letter

References (4)

1. Scheinfeld N. Imatinib mesylate and dermatology. Part 2: a review of the cutaneous side-effects of imatinib mesylate. J Drugs Dermatol 2006; 5: 228-231.
2. ten Freyhaus K, Homey B, Bieber T, Wilsmann-Theis D. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?Br J Dermatol 2008; 159: 242-243.
3. Dean SM, Zirwas M. A second case of sunitinib-associated pyoderma gangrenosum. J Clin Aesthet Dermatol 2010; 3: 34-35.
4. Sagara R, Kitami A, Nakada T, Iijima M. Adverse reactions to gefitinib (Iressa): revealing sycosis- and pyoderma gangrenosum-like lesions. Int J Dermatol 2006; 45: 1002-1003.